Creative Planning’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.79M | Buy |
14,245
+3,422
| +32% | +$430K | ﹤0.01% | 1405 |
|
2025
Q1 | $1.2M | Sell |
10,823
-8,661
| -44% | -$958K | ﹤0.01% | 1570 |
|
2024
Q4 | $2.66M | Buy |
19,484
+6,485
| +50% | +$885K | ﹤0.01% | 963 |
|
2024
Q3 | $1.5M | Buy |
12,999
+1,426
| +12% | +$164K | ﹤0.01% | 1244 |
|
2024
Q2 | $1.59M | Buy |
11,573
+30
| +0.3% | +$4.13K | ﹤0.01% | 1104 |
|
2024
Q1 | $1.59M | Buy |
11,543
+1,829
| +19% | +$252K | ﹤0.01% | 1067 |
|
2023
Q4 | $1.28M | Buy |
9,714
+1,452
| +18% | +$191K | ﹤0.01% | 1106 |
|
2023
Q3 | $929K | Buy |
8,262
+841
| +11% | +$94.6K | ﹤0.01% | 1192 |
|
2023
Q2 | $700K | Sell |
7,421
-101
| -1% | -$9.52K | ﹤0.01% | 1330 |
|
2023
Q1 | $761K | Buy |
7,522
+708
| +10% | +$71.7K | ﹤0.01% | 1220 |
|
2022
Q4 | $814K | Sell |
6,814
-492
| -7% | -$58.8K | ﹤0.01% | 1136 |
|
2022
Q3 | $776K | Buy |
7,306
+2,164
| +42% | +$230K | ﹤0.01% | 1073 |
|
2022
Q2 | $501K | Buy |
5,142
+1,102
| +27% | +$107K | ﹤0.01% | 1308 |
|
2022
Q1 | $379K | Sell |
4,040
-16
| -0.4% | -$1.5K | ﹤0.01% | 1486 |
|
2021
Q4 | $345K | Buy |
4,056
+128
| +3% | +$10.9K | ﹤0.01% | 1525 |
|
2021
Q3 | $377K | Buy |
3,928
+278
| +8% | +$26.7K | ﹤0.01% | 1457 |
|
2021
Q2 | $355K | Sell |
3,650
-261
| -7% | -$25.4K | ﹤0.01% | 1467 |
|
2021
Q1 | $380K | Sell |
3,911
-2,394
| -38% | -$233K | ﹤0.01% | 1601 |
|
2020
Q4 | $604K | Buy |
6,305
+282
| +5% | +$27K | ﹤0.01% | 1185 |
|
2020
Q3 | $579K | Buy |
6,023
+459
| +8% | +$44.1K | ﹤0.01% | 1044 |
|
2020
Q2 | $679K | Buy |
5,564
+125
| +2% | +$15.3K | ﹤0.01% | 891 |
|
2020
Q1 | $471K | Sell |
5,439
-59
| -1% | -$5.11K | ﹤0.01% | 966 |
|
2019
Q4 | $591K | Buy |
5,498
+210
| +4% | +$22.6K | ﹤0.01% | 1016 |
|
2019
Q3 | $477K | Buy |
5,288
+20
| +0.4% | +$1.8K | ﹤0.01% | 1085 |
|
2019
Q2 | $445K | Sell |
5,268
-115
| -2% | -$9.71K | ﹤0.01% | 1142 |
|
2019
Q1 | $474K | Buy |
5,383
+62
| +1% | +$5.46K | ﹤0.01% | 1048 |
|
2018
Q4 | $380K | Buy |
5,321
+23
| +0.4% | +$1.64K | ﹤0.01% | 1092 |
|
2018
Q3 | $651K | Buy |
5,298
+280
| +6% | +$34.4K | ﹤0.01% | 937 |
|
2018
Q2 | $493K | Buy |
5,018
+30
| +0.6% | +$2.95K | ﹤0.01% | 1070 |
|
2018
Q1 | $414K | Buy |
4,988
+20
| +0.4% | +$1.66K | ﹤0.01% | 1165 |
|
2017
Q4 | $385K | Sell |
4,968
-20
| -0.4% | -$1.55K | ﹤0.01% | 1212 |
|
2017
Q3 | $306K | Sell |
4,988
-235
| -4% | -$14.4K | ﹤0.01% | 1309 |
|
2017
Q2 | $240K | Sell |
5,223
-143
| -3% | -$6.57K | ﹤0.01% | 1401 |
|
2017
Q1 | $232K | Sell |
5,366
-177
| -3% | -$7.65K | ﹤0.01% | 1392 |
|
2016
Q4 | $215K | Buy |
5,543
+205
| +4% | +$7.95K | ﹤0.01% | 1371 |
|
2016
Q3 | $270K | Buy |
5,338
+38
| +0.7% | +$1.92K | ﹤0.01% | 1224 |
|
2016
Q2 | $241K | Hold |
5,300
| – | – | ﹤0.01% | 1160 |
|
2016
Q1 | $210K | Sell |
5,300
-5,400
| -50% | -$214K | ﹤0.01% | 1183 |
|
2015
Q4 | $605K | Buy |
10,700
+10,000
| +1,429% | +$565K | 0.01% | 673 |
|
2015
Q3 | $28K | Sell |
700
-26,200
| -97% | -$1.05M | ﹤0.01% | 2453 |
|
2015
Q2 | $1.29M | Buy |
26,900
+26,600
| +8,867% | +$1.27M | 0.01% | 400 |
|
2015
Q1 | $12K | Hold |
300
| – | – | ﹤0.01% | 3046 |
|
2014
Q4 | $7K | Buy |
+300
| New | +$7K | ﹤0.01% | 3259 |
|
2014
Q2 | – | Sell |
-500
| Closed | -$8K | – | 3765 |
|
2014
Q1 | $8K | Hold |
500
| – | – | ﹤0.01% | 2807 |
|
2013
Q4 | $5K | Buy |
+500
| New | +$5K | ﹤0.01% | 2841 |
|
2013
Q3 | – | Sell |
-4,500
| Closed | -$60K | – | 3305 |
|
2013
Q2 | $60K | Buy |
+4,500
| New | +$60K | ﹤0.01% | 1278 |
|